Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

Europe Human Coagulation Factor VIII Market 2016 Industry Trend and Forecast 2021

  • QYR582445
  • 134 Pages
  • May 2016
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
The Europe Human Coagulation Factor VIII Market 2016 Industry Trend and Forecast 2021 is a professional and in-depth study on the current state of the human coagulation factor VIII industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The human coagulation factor VIII market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on Europe major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The human coagulation factor VIII industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 194 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents 1 Industry Overview 1

1.1 Definition and Specifications of Human Coagulation Factor VIII 1

1.1.1 Definition of Human Coagulation Factor VIII 1

1.1.2 Specifications of Human Coagulation Factor VIII 2

1.2 Classification of Human Coagulation Factor VIII 3

1.2.1 Recombinant Factor VIII 3

1.2.2 Plasma-derived Factor VIII 4

1.3 Applications of Human Coagulation Factor VIII 5

1.3.1 Hemophilia A 6

1.3.2 Spontanous + Traum 6

1.3.3 Surgical 7

1.4 Industry Chain Structure of Human Coagulation Factor VIII 7

1.5 Industry Overview of Human Coagulation Factor VIII 8

1.6 Industry Policy Analysis of Human Coagulation Factor VIII 9

1.7 Industry News Analysis of Human Coagulation Factor VIII 9

2 Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII 11

2.1 Bill of Materials (BOM) of Human Coagulation Factor VIII 11

2.1.1 Global Plasma Volume Analysis 12

2.1.2 Numbers of Plasma Collection Stations Analysis 14

2.1.3 Price Comparison of United States Cell Culture Media 15

2.2 Equipment Suppliers Analysis of Human Coagulation Factor VIII 15

2.3 Labor Cost Analysis of Human Coagulation Factor VIII 18

2.4 Other Costs Analysis of Human Coagulation Factor VIII 19

2.5 Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII 20

2.6 Manufacturing Process Analysis of Human Coagulation Factor VIII 20

3 Technical Data and Manufacturing Plants Analysis 22

3.1 Commercial Production Date of Europe Key Manufacturers in 2015 22

3.2 Manufacturing Plants Distribution of Europe Key Human Coagulation Factor VIII Manufacturers in 2015 22

3.3 R&D Status and Technology Source of Europe Human Coagulation Factor VIII Key Manufacturers in 2015 23

4 Production Analysis of Human Coagulation Factor VIII by Regions, Product Types, and Applications 24

4.1 Europe Production of Human Coagulation Factor VIII by Regions (Key State) 2011-2016 24

4.2 Europe Production of Human Coagulation Factor VIII by Product Types 2011-2016 28

4.3 Europe Sales of Human Coagulation Factor VIII by Applications 2011-2016 31

4.4 Price Analysis of Europe Human Coagulation Factor VIII Key Manufacturers in 2015 35

4.5 Europe Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Human Coagulation Factor VIII 2011-2016 36

5 Consumption Volume and Consumption Value Analysis of Human Coagulation Factor VIII by Regions 37

5.1 Europe Consumption Volume of Human Coagulation Factor VIII by Regions 2011-2016 37

5.2 Europe Consumption Value of Human Coagulation Factor VIII by Regions 2011-2016 41

5.3 Europe Consumption Price Analysis of Human Coagulation Factor VIII by Regions 2011-2016 45

6 Analysis of Human Coagulation Factor VIII Production, Supply, Sales and Market Status 2011-2016 46

6.1 Capacity, Production, Sales, and Revenue of Human Coagulation Factor VIII 2011-2016 46

6.2 Production Market Share and Sales Market Share of Human Coagulation Factor VIII 2011-2016 51

6.3 Sales Overview of Human Coagulation Factor VIII 2011-2016 57

6.4 Supply, Consumption and Gap of Human Coagulation Factor VIII 2011-2016 59

6.5 Import, Export and Consumption of Human Coagulation Factor VIII 2011-2016 59

6.6 Cost, Price, Revenue and Gross Margin of Human Coagulation Factor VIII 2011-2016 59

7 Analysis of Human Coagulation Factor VIII Industry Key Manufacturers 62

7.1 Baxter 62

7.1.1 Company Profile 62

7.1.2 Product Picture and Specifications 63

7.1.2.1 ADVATE (Recombinant coagulation factor VIII) 63

7.1.2.2 Recombinant 63

7.1.3 Capacity, Production, Price, Cost, Gross and Revenue 64

7.2 Bayer 65

7.2.1 Company Profile 65

7.2.2 Product Picture 66

7.2.2.1 Kogenate® FS, antihemophilic factor (recombinant) 66

7.2.3 Capacity, Production, Price, Cost, Gross and Revenue 67

7.3 Pfizer 68

7.3.1 Company Profile 68

7.3.2 Product Picture 70

7.3.2.1 XYNTHA® (antihemophilic factor (recombinant)) 70

7.3.2.2 REFACTO® (antihemophilic factor (recombinant)) 71

7.3.3 Capacity, Production, Price, Cost, Gross and Revenue 71

7.4 CSL 73

7.4.1 Company Profile 73

7.4.2 Product Picture and Specifications 74

7.4.2.1 Helixate FS (Recombinant coagulation factor VIII) 74

7.4.2.2 Helixate® NexGen 75

7.4.2.3 Humate-P® 75

7.4.2.4 Biostate® 76

7.4.2.5 Beriate? (Human coagulation factor VIII) 76

7.4.2.6 Monoclate-P® 77

7.4.3 Capacity, Production, Price, Cost, Gross and Revenue 77

7.5 Grifols 79

7.5.1 Company Profile 79

7.5.2 Product Picture and Specification 80

7.5.2.1 Fanhdi® 80

7.5.3 Capacity, Production, Price, Cost, Gross and Revenue 80

7.6 Octapharma 82

7.6.1 Company Profile 82

7.6.2 Product Picture and Specifications 83

7.6.2.1 nuwiq®( human coagulation factor VIII recombinant DNA) 83

7.6.2.2 octanate® 84

7.6.2.3 wilate® 84

7.6.3 Capacity, Production, Price, Cost, Gross and Revenue 85

7.7 BPL 87

7.7.1 Company Profile 87

7.7.2 Product Picture 88

7.7.2.1 Optivate 88

7.7.3 Capacity, Production, Price, Cost, Gross and Revenue 89

7.8 Kedrion 90

7.8.1 Company Profile 90

7.8.2 Product Picture 91

7.8.2.1 Human Coagulation Factor VIII (10ml) 91

7.8.2.2 Human Coagulation Factor VIII (5ml) 92

7.8.3 Capacity, Production, Price, Cost, Gross and Revenue 92

8 Price and Gross Margin Analysis 94

8.1 Analysis of Price 94

8.2 Gross Margin Analysis 94

8.3 Price Comparison by Regions 95

8.4 Price Analysis of Different Human Coagulation Factor VIII Product Types 95

8.5 Gross Margin Analysis of Different Human Coagulation Factor VIII Applications 95

9 Marketing Trader or Distributor Analysis of Human Coagulation Factor VIII 97

9.1 Marketing Channels Status of Human Coagulation Factor VIII 97

9.2 Traders or Distributors of Human Coagulation Factor VIII with Contact Information 98

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Human Coagulation Factor VIII 99

9.4 Europe Import, Export and Trade Analysis of Human Coagulation Factor VIII 99

10 Development Trend of Human Coagulation Factor VIII Industry 2016-2021 100

10.1 Capacity and Production Overview of Human Coagulation Factor VIII 2016-2021 100

10.2 Production Market Share by Product Types of Human Coagulation Factor VIII 2016-2021 101

10.3 Sales and Sales Revenue Overview of Human Coagulation Factor VIII 2016-2021 102

10.4 Europe Sales of Human Coagulation Factor VIII by Applications 2016-2021 103

10.5 Import, Export and Consumption of Human Coagulation Factor VIII 2016-2021 104

10.6 Cost, Price, Revenue and Gross Margin of Human Coagulation Factor VIII 2016-2021 105

11 Industry Chain Suppliers of Human Coagulation Factor VIII with Contact Information 106

11.1 Major Raw Materials Suppliers of Human Coagulation Factor VIII with Contact Information 106

11.2 Manufacturing Equipment Suppliers of Human Coagulation Factor VIII with Contact Information 107

11.3 Major Players of Human Coagulation Factor VIII with Contact Information 110

11.4 Key Consumers of Human Coagulation Factor VIII with Contact Information 111

11.5 Supply Chain Relationship Analysis of Human Coagulation Factor VIII 112

12 New Project Investment Feasibility Analysis of Human Coagulation Factor VIII 113

12.1 New Project SWOT Analysis of Human Coagulation Factor VIII 113

12.2 New Project Investment Feasibility Analysis of Human Coagulation Factor VIII 113

13 Conclusion of the Europe Human Coagulation Factor VIII Industry Report 2015 115

List of Tables and FiguresListList

Figure Picture of Human Coagulation Factor VIII (Plasma-derived Factor VIII) 2

Table Specifications of Human Coagulation Factor VIII 2

Table Specification Comparison of Human Coagulation Factor VIII 3

Figure Europe Production Market Share of Human Coagulation Factor VIII by Type in 2015 3

Figure Recombinant Factor VIII Picture 4

Figure Plasma-derived Factor VIII Picture 4

Table Applications of Human Coagulation Factor VIII 5

Figure 2015 Europe Human Coagulation Factor VIII Major Applications Sales Share 5

Figure Typical Application in Hemophilia A 6

Figure Typical Application in Spontanous + Traum 6

Figure Typical Application in Surgical 7

Figure Industry Chain Structure of Human Coagulation Factor VIII 7

Table Europe Human Coagulation Factor VIII Major Manufacturers 8

Figure Europe Human Coagulation Factor VIII Major Regions Status in 2015 8

Table Industry Policy of Human Coagulation Factor VIII 9

Table Industry News List of Human Coagulation Factor VIII 9

Table Bill of Materials (BOM) of Human Coagulation Factor VIII 11

Table Global Plasma Volume by Region 2011-2016 (M Liter) 12

Table Global Plasma Market Share by Region 2011-2016 12

Figure Global Plasma Market Share by Region 2011 13

Figure Global Plasma Market Share by Region 2015 13

Table Global Major Manufacturers Plasma volume 2011-2016 (M Liter) 14

Table Numbers of Blood Collection Stations 2011-2016 14

Figure Price Comparison of Cell Culture Media 2011-2016 15

Table the key equipment of Human Coagulation Factor VIII 15

Figure Equipment Specification of Industrial Centrifuges 17

Figure Equipment Specification of Industrial Incubator 18

Figure European 2014 Estimated Hourly Labor Costs 18

Table 2015 Europe Electricity Price of Industry (USD/KW•h) by Country 19

Table Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII in 2015 20

Figure Manufacturing Process Analysis of Recombinant Factor VIII 20

Figure Manufacturing Process Analysis of Plasma-derived Factor VIII 21

Table Commercial Production Date of Europe Human Coagulation Factor VIII Key Manufacturers in 2015 22

Table Manufacturing Plants Distribution of Europe Key Human Coagulation Factor VIII Manufacturers in 2015 22

Table R&D Status and Technology Source of Europe Human Coagulation Factor VIII Key Manufacturers in 2015 23

Table Europe Production of Human Coagulation Factor VIII by Regions 2011-2016 (K Bottles) 24

Table Europe Production Market Share of Human Coagulation Factor VIII by Regions 2011-2016 24

Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2011 25

Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2012 25

Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2013 26

Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2014 26

Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2015 27

Figure Europe Production Market Share of Human Coagulation Factor VIII by Regions in 2016 27

Table Europe Production of Human Coagulation Factor VIII by Product Types in 2011-2016 (K Bottles) 28

Table Europe Production Market Share of Human Coagulation Factor VIII by Product Types in 2011-2016 28

Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2011 28

Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2012 29

Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2013 29

Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2014 30

Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2015 30

Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2016 31

Table Europe Sales of Human Coagulation Factor VIII by Applications 2011-2016 (K Bottles) 31

Table Europe Sales Market Share of Human Coagulation Factor VIII by Applications 2011-2016 31

Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2011 32

Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2012 32

Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2013 33

Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2014 33

Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2015 34

Figure Europe Sales Market Share of Human Coagulation Factor VIII by Applications in 2016 34

Figure Price Comparison of Europe Human Coagulation Factor VIII Key Manufacturers in 2015 (USD/Bottle) 35

Table Europe Capacity, Production, Import Export Sales Price, Cost and Revenue (M USD) of Human Coagulation Factor VIII 2011-2016 36

Table Europe Consumption Volume of Human Coagulation Factor VIII by Regions 2011-2016 (K Bottles) 37

Table Europe Consumption Volume Market Share of Human Coagulation Factor VIII by Regions 2011-2016 37

Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2011 38

Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2012 38

Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2013 39

Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2014 39

Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2015 40

Figure Europe Consumption Volume of Human Coagulation Factor VIII by Regions in 2016 40

Table Europe Consumption Value of Human Coagulation Factor VIII by Regions 2011-2016 (M USD) 41

Table Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions 2011-2016 41

Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2011 42

Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2012 42

Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2013 43

Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2014 43

Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2015 44

Figure Europe Consumption Value Market Share of Human Coagulation Factor VIII by Regions in 2016 44

Table Consumption Price of Human Coagulation Factor VIII by Regions 2011-2016 (USD/Bottle) 45

Table Europe and Major Manufacturers Capacity of Human Coagulation Factor VIII 2011-2016 (K Bottles) 46

Table Europe Capacity Market Share of Major Human Coagulation Factor VIII Manufacturers 2011-2016 46

Table Europe and Major Manufacturers Production of Human Coagulation Factor VIII 2011-2016 (K Bottles) 47

Table Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers 2011-2016 47

Table Europe and Major Manufacturers Sales of Human Coagulation Factor VIII 2011-2016 (K Bottles) 47

Table Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers 2011-2016 48

Table Europe and Major Manufacturers Sales Revenue of Human Coagulation Factor VIII 2011-2016 (M USD) 48

Table Europe Sales Revenue Market Share of Major Human Coagulation Factor VIII Manufacturers 2011-2016 49

Figure Europe Capacity (K Bottles), Production (K Bottles) and Growth Rate of Human Coagulation Factor VIII 2011-2016 49

Figure Europe Capacity Utilization Rate of Human Coagulation Factor VIII 2011-2016 50

Figure Europe Sales Revenue (M USD) and Growth Rate of Human Coagulation Factor VIII 2011-2016 50

Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2011 51

Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2012 51

Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2013 52

Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2014 52

Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2015 53

Figure Europe Production Market Share of Major Human Coagulation Factor VIII Manufacturers in 2016 53

Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2011 54

Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2012 54

Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2013 55

Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2014 55

Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2015 56

Figure Europe Sales Market Share of Major Human Coagulation Factor VIII Manufacturers in 2016 56

Figure Europe Sales (K Bottles) and Growth Rate of Human Coagulation Factor VIII 2011-2016 57

Table Europe and Major Manufacturers Local Sales of Human Coagulation Factor VIII 2011-2016 (K Bottles) 58

Table Europe and Major Manufacturers Export of Human Coagulation Factor VIII 2011-2016 (K Bottles) 58

Table Europe Supply, Consumption and Gap of Human Coagulation Factor VIII 2011-2016 (K Bottles) 59

Table Europe Import, Export and Consumption of Human Coagulation Factor VIII 2011-2016 (K Bottles) 59

Table Price of Europe Human Coagulation Factor VIII Major Manufacturers 2011-2016 (USD/Bottle) 59

Table Gross Margin of Europe Human Coagulation Factor VIII Major Manufacturers 2011-2016 60

Table Europe and Major Manufacturers Revenue of Human Coagulation Factor VIII 2011-2016 (M USD) 60

Table Europe Production (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Revenue (M USD) and Gross Margin of Human Coagulation Factor VIII 2011-2016 61

Table Baxter Company Profile List 62

Figure ADVATE Product Picture of Baxter 63

Figure Recombinant Product Picture of Baxter 63

Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Baxter 2011-2016 64

Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of Baxter 2011-2016 64

Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Baxter 2011-2016 65

Table Bayer Company Profile List 65

Figure Kogenate® FS, antihemophilic factor (recombinant) Product Picture of Bayer 66

Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Bayer 2011-2016 67

Figure Human Coagulation Factor VIII Local Sales (K Bottles) and Growth Rate of Bayer 2011-2016 67

Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Bayer 2011-2016 68

Table Pfizer Company Profile List 68

Figure XYNTHA® (antihemophilic factor (recombinant)) Product Picture of Pfizer 70

Figure REFACTO® (antihemophilic factor (recombinant)) Product Picture of Pfizer 71

Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Pfizer 2011-2016 71

Figure Human Coagulation Factor VIII Local Sales (K Bottles) and Growth Rate of Pfizer 2011-2016 72

Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Pfizer 2011-2016 72

Table CSL Company Profile List 73

Figure Helixate FS Product Picture of CSL 74

Figure Helixate® NexGen Product Picture of CSL 75

Figure Humate-P® Product Picture of CSL 75

Figure Biostate® Product Picture of CSL 76

Figure Beriate? Product Picture of CSL 76

Figure Monoclate-P® Product Picture of CSL 77

Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of CSL 2011-2016 77

Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of CSL 2011-2016 78

Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of CSL 2011-2016 78

Table Grifols Company Profile List 79

Figure Fanhdi® Product Picture of Grifols 80

Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Grifols 2011-2016 80

Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of Grifols 2011-2016 81

Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Grifols 2011-2016 81

Table Octapharma Company Profile List 82

Figure nuwiq® Product Picture of Octapharma 83

Figure octanate® Product Picture of Octapharma 84

Figure wilate® Product Picture of Octapharma 84

Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Octapharma 2011-2016 85

Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of Octapharma 2011-2016 86

Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Octapharma 2011-2016 86

Table BPL Company Profile List 87

Figure Optivate Product Picture of BPL 88

Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of BPL 2011-2016 89

Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of BPL 2011-2016 89

Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of BPL 2011-2016 90

Table Kedrion Company Profile List 90

Figure Human Coagulation Factor VIII (10ml) Product Picture of Kedrion 91

Figure Human Coagulation Factor VIII (5ml) Product Picture of Kedrion 92

Table Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles), Local Sales (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Gross (USD/Bottle), Revenue (M USD) and Gross Margin of Kedrion 2011-2016 92

Figure Human Coagulation Factor VIII Capacity (K Bottles), Production (K Bottles) and Growth Rate of Kedrion 2011-2016 93

Figure Human Coagulation Factor VIII Revenue (M USD) and Market Share of Kedrion 2011-2016 93

Table Human Coagulation Factor VIII Price by Product Types 2011-2016 (USD/Bottle) 94

Table Human Coagulation Factor VIII Price by Companies 2011-2016 (USD/Bottle) 94

Table Human Coagulation Factor VIII Gross Margin by Companies 2011-2016 94

Table Price Comparison of Human Coagulation Factor VIII by Regions 2011-2016 (USD/Bottle) 95

Table Price of Different Human Coagulation Factor VIII Product Types (USD/Bottle) 95

Table Gross Margin of Different Human Coagulation Factor VIII Applications 95

Figure Marketing Channels Analysis of Human Coagulation Factor VIII 97

Table Traders or Distributors of Human Coagulation Factor VIII with Contact Information 98

Figure Ex-work Price, Channel Price and End Buyer Price of Human Coagulation Factor VIII (USD/Bottle) in 2015 99

Table Europe Import, Export, and Trade of Human Coagulation Factor VIII (K Bottles) 99

Figure Europe Capacity (K Bottles), Production (K Bottles) and Growth Rate of Human Coagulation Factor VIII 2016-2021 100

Figure Europe Capacity Utilization Rate of Human Coagulation Factor VIII 2016-2021 101

Table Europe Human Coagulation Factor VIII Production by Product Types 2011-2016 (K Bottles) 101

Table Europe Human Coagulation Factor VIII Production Market Share by Product Types 2011-2016 101

Figure Europe Production Market Share of Human Coagulation Factor VIII by Technology in 2021 102

Figure Europe Sales (K Bottles) and Growth Rate of Human Coagulation Factor VIII 2016-2021 102

Figure Europe Sales Revenue (Million USD) and Growth Rate of Human Coagulation Factor VIII 2016-2021 103

Figure Europe Sales of Human Coagulation Factor VIII by Applications 2016-2021 (K Bottles) 103

Table Europe Production Market Share of Human Coagulation Factor VIII by Applications 2016-2021 103

Figure Europe Production Market Share of Human Coagulation Factor VIII by Applications in 2021 104

Table Europe Production, Import, Export and Consumption of Human Coagulation Factor VIII 2016-2021 (K Bottles) 104

Table Europe Production (K Bottles), Price (USD/Bottle), Cost (USD/Bottle), Revenue (M USD) and Gross Margin of Human Coagulation Factor VIII 2016-2021 105

Table Major Raw Materials Suppliers of Human Coagulation Factor VIII with Contact Information 106

Table Manufacturing Equipment Suppliers of Human Coagulation Factor VIII with Contact Information 107

Table Major Players of Human Coagulation Factor VIII with Contact Information 110

Table Key Consumers of Human Coagulation Factor VIII with Contact Information 111

Figure Supply Chain Relationship Analysis of Human Coagulation Factor VIII 112

Table New Project SWOT Analysis of Human Coagulation Factor VIII 113

Table New Project Investment Feasibility Analysis of Human Coagulation Factor VIII 113

Author List 116

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2017-2021 UK Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.

Summary

This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...

  • Publish Date: February 7, 2017
  • $750
2017-2021 US Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

Summary

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...

  • Publish Date: February 7, 2017
  • $750
2017-2021 Immunohematology and Infectious Disease Screening Market: Competitive Analysis of Major Suppliers and Emerging Market Entrants

This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Con...

  • Publish Date: February 7, 2017
  • $750